SONM stock news
This page provides real-time market news, earnings updates, and company announcements related to DNA X, Inc. (SONM).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-07 12:44 EST
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-27 13:03:11
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ
Finviz2026-02-27 13:36:43
NeOnc Technologies: Evaluating the Rapid Growth Prospects of a Platform Capable of Crossing the Blood-Brain Barrier
101 finance2026-02-27 14:24:52
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
Finviz2026-02-28 07:24:44
Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat
Finviz2026-03-01 09:24:41
Nexxen Announces February 2026 Share Repurchase Program Summary
Finviz2026-03-02 12:33:45
3 Loss-Making Stocks We Handle Carefully
101 finance2026-03-02 16:03:16
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Finviz2026-03-02 21:09:43
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
Finviz2026-03-03 12:04:19
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Finviz2026-03-03 13:03:51
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
Boundless Bio to Participate in the Leerink Global Healthcare Conference
Finviz2026-03-04 12:03:13
Life Sciences Tools & Services Stocks Fourth Quarter Review: Comparing PacBio (NASDAQ:PACB)
101 finance2026-03-04 12:15:14
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
Finviz2026-03-04 12:21:56
Life Sciences Tools & Services Stocks Fourth Quarter Overview: Comparing PacBio (NASDAQ:PACB)
101 finance2026-03-04 12:15:14
Mapping the S-Curve: INOVIO's Partnership in GBM as a Strategic Move Toward Advancing DNA Immunotherapy Platforms
101 finance2026-03-04 13:30:53
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
Finviz2026-03-04 13:03:48
Vishay Intertechnology RGB LED in 0404 Package Provides Independent Control of Red, True Green, and Blue Chips for Wide Color Range
Finviz2026-03-04 16:03:02
BillionToOne: Overview of Fourth Quarter Financial Results
101 finance2026-03-04 21:48:14
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
Finviz2026-03-04 22:03:44
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-06 12:46:17
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
Finviz2026-03-06 15:22:06
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
Finviz2026-03-06 15:25:25
Life Sciences Tools & Services Stocks Q4 Overview: Comparing 10x Genomics (NASDAQ:TXG) With Its Competitors
101 finance2026-03-06 22:57:39
Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat
Finviz2026-03-01 09:24:41
Nexxen Announces February 2026 Share Repurchase Program Summary
Finviz2026-03-02 12:33:45
3 Loss-Making Stocks We Handle Carefully
101 finance2026-03-02 16:03:16
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Finviz2026-03-02 21:09:43
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
Finviz2026-03-03 12:04:19
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Finviz2026-03-03 13:03:51
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
Boundless Bio to Participate in the Leerink Global Healthcare Conference
Finviz2026-03-04 12:03:13
Life Sciences Tools & Services Stocks Fourth Quarter Review: Comparing PacBio (NASDAQ:PACB)
101 finance2026-03-04 12:15:14
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
Finviz2026-03-04 12:21:56
Life Sciences Tools & Services Stocks Fourth Quarter Overview: Comparing PacBio (NASDAQ:PACB)
101 finance2026-03-04 12:15:14
Mapping the S-Curve: INOVIO's Partnership in GBM as a Strategic Move Toward Advancing DNA Immunotherapy Platforms
101 finance2026-03-04 13:30:53
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
Finviz2026-03-04 13:03:48
Vishay Intertechnology RGB LED in 0404 Package Provides Independent Control of Red, True Green, and Blue Chips for Wide Color Range
Finviz2026-03-04 16:03:02
BillionToOne: Overview of Fourth Quarter Financial Results
101 finance2026-03-04 21:48:14
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
Finviz2026-03-04 22:03:44
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-06 12:46:17
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
Finviz2026-03-06 15:22:06
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
Finviz2026-03-06 15:25:25
Life Sciences Tools & Services Stocks Q4 Overview: Comparing 10x Genomics (NASDAQ:TXG) With Its Competitors
101 finance2026-03-06 22:57:39
SONM stock chart
SONM stock detailsSONM stock price change
On the last trading day, SONM stock closed at 5.04 USD, with a price change of 0.10% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more